Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).


TSXV:VPT - Post by User

Comment by bluemoons20on Dec 13, 2021 10:58pm
111 Views
Post# 34227647

RE:RE:Just reading up a bit on the EBSCOhost

RE:RE:Just reading up a bit on the EBSCOhostChanging the multiple  is nice  and I would love it  but  since this is a specific application,  it is not a huge market and it really comes down to a finite number of units until you cap out.  So with the  financing (  and hence dilution)  Do you really get those kinds of multiples??

Or just a  current value of future potential sales    Maybe  $3  to  max  $5.   Would love it  but do not see this  @  $10.

\Would love to know what is happenning behind the scenes.  First we have money for three years  , then  a surprise financing  and building our own  units  and  now  talk of  just software?   Seems like a lot of bobbing and weaving going on here.  And then  the note about  end of  2022  (and that is just  to complete  , not  test  and then  sell???

As I have said  before  , as every day goes on this is looking like a longer and longer hold.  That is why  I personally  am not continuing to  buy  shares

GLTA
<< Previous
Bullboard Posts
Next >>